Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

Item
http://www.wikidata.org/entity/Q36730935
Dinosaurs and ancient civilizations: reflections on the treatment of cancerGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsTumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage ResponseGenomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationMEIG1 is essential for spermiogenesis in mice.Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiencyNeoplasia: the second decade.Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and ProgressionGenomic profiling of renal cell carcinoma in patients with end-stage renal disease.Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinomaGenetic determinants at the interface of cancer and neurodegenerative disease.Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patients.FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaAutocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways.Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resectionStratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisNotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.The War on Cancer rages on.The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer.Renal cell carcinoma deep sequencing: recent developments.An emerging role of PARK2 in cancer.Very large common fragile site genes and their potential role in cancer development.WWOX, large common fragile site genes, and cancer.PARKIN Inactivation Links Parkinson's Disease to Melanoma.Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
P2860
Q24628746-E4B0E40A-8D81-4723-A37A-ACCF32F75083Q26785930-25A4D7DB-9142-46EC-8A4C-0EB6F46397EAQ28070247-B1AFAA1C-20D1-4739-9D69-8F137B50F006Q28728573-02E7D23E-31FD-46AB-97D0-8477BE385353Q30438531-BBE5F5E0-FEC4-48A1-A80B-7CA0BCD8CBF2Q30465158-581FB746-3871-4D16-822B-EB2851A4E35EQ30484000-735BCC5F-E1FB-4305-B060-B907F597C4B6Q33616134-CDA9B09D-024E-4BE6-8FFB-0F928D3CBFEFQ33904883-AC670457-E822-4D78-B495-06667F6BA380Q34018955-6BA248F1-CAD2-43CC-94C3-A75FC180C822Q34092758-7BB59195-3964-49D5-B643-7C2EB2E65D4DQ34098513-4A614086-E611-49FF-9BB0-3A6843D23B49Q34186632-522B9FBD-639D-4BDC-943E-2BB0C1E351FEQ34193780-542D581D-8F0D-44F0-8C0E-1C73224AB412Q34422582-588432BC-5F0E-4045-BCC0-3245EBEF6D3DQ34640574-92DB890E-7CAF-4126-BFF3-FFD78E82501CQ35167200-77F73DD8-A86B-48CE-A930-D3EFFD1127F3Q35606411-2B114CAD-D1C7-4AC7-9D4C-71B4F264557BQ35653176-925D129F-B8CB-4B94-B06F-39D9EE72B50DQ35882196-0B8F2501-B387-4149-833D-283D45900DDEQ36087804-2D9CDB35-8D54-40CF-BD4D-7733AFD4ACC3Q36367103-F22D03BF-865C-4D2E-A664-EEB261313AAAQ36396570-B8F0DEF8-1196-4C99-B152-DE65AD10FF9FQ36736210-A1BCEC32-43B0-4EC4-8548-2A43EE7AB402Q37165838-19EB76BA-FDD9-4BAC-BA69-53F4B7909CBBQ37401031-94E49410-2E5E-4A4D-8B59-C4F926947CF3Q37478602-27213C82-FD89-44D0-A77E-3277CADBB14FQ37886251-8D61949E-6BAA-4F77-88EB-743CEDF10F8FQ38005625-DBDCEF71-5970-4E1D-A608-105A8CB5852AQ38168127-9AB758F0-03C3-4B48-8ED6-7891A8E0C36CQ38258543-070D7CD5-876A-4885-92DE-DD5A5544BF83Q38321093-119B2422-A634-4778-9B4B-CDF556F6E35DQ38810658-41F86651-E7AA-4093-BF87-495F397FCE8AQ39009613-33F51BA4-E8F1-4060-AF4E-61E4E125EC59Q39341646-235D58DD-2077-40D6-9A34-2028D67432D0Q41037797-74A32D2D-4EF6-4208-9741-F3751D18222FQ41574276-2BA85716-57BA-4DB9-B71E-6BDC706913A8Q42026232-FFF635E7-8BCC-4C4F-9812-60F9064DE480Q43806776-C8B3566E-FACC-4CED-88B1-172FE8609EA3Q45980708-8CB24151-1A87-4895-9C66-02CC8F8B1769
P2860

Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

Item
http://www.wikidata.org/entity/Q36730935
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@ast
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@en
type
label
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@ast
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@en
prefLabel
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@ast
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Loss of heterozygosity and cop ...... de polymorphism mapping array.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932